Strand life Sciences

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare…

Dr Swaraj Basu highlights how structured, standardised and connected genomic data can drive meaningful breakthroughs in research…

Despite challenges, diagnostics in tier 2 and 3 cities are growing through PPPs and technology adoption

APAC's CT market poised for steady growth amid rising demand and technological innovation

The best-in-class portfolio of prenatal screening and diagnostics uses Strand’s advanced capabilities in genomic analytics

The companies will join forces to advance the use of precision medicine on a global scale 

The new cutting-edge instruments will drive Strand's clinical genomic tests and the newly launched Genomic Health Insights (GHI)…

Based on the comprehensive genomic profiling approach which detects multiple actionable cancer biomarkers at ‘one go’ to optimise…

Oncquest Laboratories has acquired Quest Diagnostic’s Indian facilities from Strand Life Sciences. The acquisition is expected to…

HCG’s partnership with Strand Life Sciences has allowed the hospital to look meticulously at building efficient processes for…